Article | July 23, 2020

Study Start-up Pulse Report & Assessing Post-COVID Readiness

Strategy

The Veeva 2020 Study Start-up Pulse Report examines the life sciences industry’s progress toward streamlining study start-up by gathering the experiences and opinions of over 500 clinical operations professionals from around the globe. The goal of the research is to understand the drivers, barriers, and benefits of modernizing clinical systems and processes to accelerate trials and gives an industry-wide view of study start-up technology adoption.

Executive Summary

Findings show an urgent need to streamline study start-up processes to increase operational efficiency, quality, and speed in clinical trials.

  • All respondents say they need to improve study start-up processes. The top drivers are faster study start-up times (75%) and reduced manual processes (53%).
  • Nearly all respondents (98%) report significant challenges with study start-up, likely due to the heavy reliance on manual processes since most (81%) use spreadsheets to manage this area.
  • More than one-third say faster collection of site essential documents (44%) and easier collaboration (42%) are critical to improving study start-up.
  • Majorities say automating key study start-up processes like contracts and budgets (63%) and site essential document collection (61%) would have a significant, positive impact on trial quality and speed.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: